Kim Vanuytsel, Ph.D.

PhD: Biomedical Sciences, Molecular and Stem Cell Medicine (KU Leuven, Belgium)
Masters: Bioengineering (KU Leuven, Belgium)
Major: Cell and Gene Biotechnology
Hometown: Kasterlee, Belgium

Kim joined the lab in November 2014 after finishing her PhD at the Stem Cell Institute Leuven (SCIL), aimed at developing a human pluripotent disease model for Fanconi anemia. As a postdoc in the Murphy lab she continues her efforts to unravel hematopoietic disorders and primarily focuses on modeling β-Thalassemia using induced pluripotent stem cells (iPSCs). Besides studying what can go wrong during red blood cell development, she is also exploring ways to scale up in vitro red blood cell production.

Outside the lab Kim enjoys running, soccer, good food (eating out as well as cooking), good music (or bad music in good company) and from time to time she gets creative with paint or pencils.

This post has No Comments

Sorry, the comment form is closed at this time.

Murphy Lab Awarded Amyloidosis Foundation Grant

“Induced Pluripotent Stem Cell Modeling of Human Hereditary Amyloidosis”
This project will generate a new form of stem cells that start out as skin or blood cells but are then reprogrammed into cells that have the ability to become any type of tissue in the body. These stem cells will be utilized to study a genetic disease through the directed differentiation of these cells in vitro in order to recapitulate the outcome of the disease. Possible benefits of this research are new ways to study treatments for genetic diseases such as familial amyloidosis.

CLICK ON THE ICON TO LEARN MORE…

Dr. Murphy chosen as an American Society of Hematology Scholar

Click on the icon to read more…